Altrova Health closes $470K placement to fund US expansion
What's the deal? Altrova HealthDealroom has a profile for this one. Try Dealroom → has closed a non-brokered private placement for gross proceeds of US$491.2K (roughly $470,000), it said on October 13. The Canadian public company (CSE: ROVA) issued 13,396,800 units at US$0.04 each, with PowerOne Capital MarketsDealroom has a profile for this one. Try Dealroom → acting as finder on part of the offering.
How it's structured: Each unit pairs one common share with one warrant exercisable at US$0.04 for 36 months. Altrova paid finders US$16.1K in cash commissions and issued 439,166 finder's warrants.
What's the endgame? Altrova is building a portfolio of health products across detection, protection, treatment, and wellness. The company plans to use proceeds to execute its exclusive US distribution agreement with Reliability Funding LLCDealroom has a profile for this one. Try Dealroom →, covering inventory, customer onboarding, training, and sales.
Why now? "With this financing closed, we can move on executing our exclusive U.S. distribution agreement with Reliability," said chief executive officer Geoff Benic. He added the proceeds will "start working toward commercial traction in the U.S. market."
The signal: At roughly $470,000, this is a small raise — sitting in the bottom share of comparable rounds by size. For an early-stage, micro-cap health company, it is less a growth milestone than working capital to get a single distribution deal off the ground.
Read more: wallstreet-online.de
Image credit: Generated with Gemini
